ArticleClinical and translational gastroenterology2026
On the Correlation Between Gastrointestinal Symptoms and Sites for Endoscopic Biopsies to Diagnose Graft-Versus-Host Disease.
Article in Clinical and translational gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGastrointestinal graft-versus-host disease (GI-GVHD) is a serious complication of hematopoietic stem cell transplantation, with diagnosis reliant on results of endoscopic biopsy. Optimal endoscopic approaches based on symptoms remain unclear.
methodsWe conducted a retrospective cohort study of 75 adult hematopoietic stem cell transplantation recipients with GVHD and GI symptoms undergoing endoscopic biopsy at Montefiore Medical Center (2015-2023). We assessed correlations between presenting upper (UGI) or lower GI (LGI) symptoms and biopsy-proven GVHD. Statistical analyses included χ 2 tests, phi coefficients, and logistic regression adjusting for demographic confounders. A subgroup analysis compared the diagnostic yield of flexible sigmoidoscopy vs full colonoscopy.
resultsBiopsy positivity strongly correlated with symptom location: 89.5% of patients with UGI symptoms had positive upper GI biopsies, and 100% with LGI symptoms had positive lower GI biopsies. χ 2 tests showed significant associations between symptoms and biopsy positivity ( P < 0.001), with phi coefficients indicating strong correlations ( r = 0.79 UGI; r = 0.82 LGI). Logistic regression confirmed symptom location as an independent predictor of biopsy results. Among 37 patients undergoing full colonoscopy, rectosigmoid biopsies showed perfect correlation with a diagnosis of GVHD ( r = 1.0, P < 0.001) when compared with other anatomic colon biopsy sites, suggesting flexible sigmoidoscopy is a cost-effective alternative for LGI symptoms. DISCUSSION: Symptom-guided endoscopic evaluation in GI-GVHD yields high diagnostic accuracy. Flexible sigmoidoscopy with targeted biopsies should be considered for patients with LGI symptoms because it may reduce procedural burden and health care costs without compromising diagnostic yield. These findings support symptom-directed, anatomically targeted approaches to improve patient care and resource utilization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.